Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size, Status and Forecast 2018-2025

Published: Aug, 2018 | Pages: 99 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report focuses on the global Pulmonary Arterial Hypertension (PAH) Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pulmonary Arterial Hypertension (PAH) Medicine development in United States, Europe and China.

In 2017, the global Pulmonary Arterial Hypertension (PAH) Medicine market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
Pfizer
Gilead Sciences
Eli Lilly
Actelion Pharmaceuticals
United Therapeutics Corporation
...

Market segment by Type, the product can be split into
Calcium Channel Blockers
Novel Targeted Drugs
Other

Market segment by Application, split into
Secondary Pulmonary Hypertension (SPH)
Primary Pulmonary Hypertension (PPH)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pulmonary Arterial Hypertension (PAH) Medicine status, future forecast, growth opportunity, key market and key players.
To present the Pulmonary Arterial Hypertension (PAH) Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pulmonary Arterial Hypertension (PAH) Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Type (2013-2025)
        1.4.2 Calcium Channel Blockers
        1.4.3 Novel Targeted Drugs
        1.4.4 Other
    1.5 Market by Application
        1.5.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2025)
        1.5.2 Secondary Pulmonary Hypertension (SPH)
        1.5.3 Primary Pulmonary Hypertension (PPH)
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Size
    2.2 Pulmonary Arterial Hypertension (PAH) Medicine Growth Trends by Regions
        2.2.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Regions (2013-2025)
        2.2.2 Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Manufacturers
        3.1.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers (2013-2018)
        3.1.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Concentration Ratio (CR5 and HHI)
    3.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players Head office and Area Served
    3.3 Key Players Pulmonary Arterial Hypertension (PAH) Medicine Product/Solution/Service
    3.4 Date of Enter into Pulmonary Arterial Hypertension (PAH) Medicine Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018)
    4.2 Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018)

5 United States
    5.1 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    5.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in United States
    5.3 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    5.4 United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

6 Europe
    6.1 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    6.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in Europe
    6.3 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    6.4 Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

7 China
    7.1 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    7.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in China
    7.3 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    7.4 China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

8 Japan
    8.1 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    8.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in Japan
    8.3 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    8.4 Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    9.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in Southeast Asia
    9.3 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    9.4 Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

10 India
    10.1 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    10.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in India
    10.3 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    10.4 India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

11 Central & South America
    11.1 Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size (2013-2018)
    11.2 Pulmonary Arterial Hypertension (PAH) Medicine Key Players in Central & South America
    11.3 Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type
    11.4 Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Pulmonary Arterial Hypertension (PAH) Medicine Introduction
        12.1.4 Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
        12.1.5 Pfizer Recent Development
    12.2 Gilead Sciences
        12.2.1 Gilead Sciences Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Pulmonary Arterial Hypertension (PAH) Medicine Introduction
        12.2.4 Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
        12.2.5 Gilead Sciences Recent Development
    12.3 Eli Lilly
        12.3.1 Eli Lilly Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Pulmonary Arterial Hypertension (PAH) Medicine Introduction
        12.3.4 Eli Lilly Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
        12.3.5 Eli Lilly Recent Development
    12.4 Actelion Pharmaceuticals
        12.4.1 Actelion Pharmaceuticals Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Pulmonary Arterial Hypertension (PAH) Medicine Introduction
        12.4.4 Actelion Pharmaceuticals Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
        12.4.5 Actelion Pharmaceuticals Recent Development
    12.5 United Therapeutics Corporation
        12.5.1 United Therapeutics Corporation Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Pulmonary Arterial Hypertension (PAH) Medicine Introduction
        12.5.4 United Therapeutics Corporation Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
        12.5.5 United Therapeutics Corporation Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures

    Table Pulmonary Arterial Hypertension (PAH) Medicine Key Market Segments
    Table Key Players Pulmonary Arterial Hypertension (PAH) Medicine Covered
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Market Share by Type 2013-2025
    Figure Calcium Channel Blockers Figures
    Table Key Players of Calcium Channel Blockers
    Figure Novel Targeted Drugs Figures
    Table Key Players of Novel Targeted Drugs
    Figure Other Figures
    Table Key Players of Other
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Growth by Application 2013-2025 (Million US$)
    Figure Secondary Pulmonary Hypertension (SPH) Case Studies
    Figure Primary Pulmonary Hypertension (PPH) Case Studies
    Figure Pulmonary Arterial Hypertension (PAH) Medicine Report Years Considered
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2025 (Million US$)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Regions 2013-2025 (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Regions 2013-2018 (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions 2013-2018
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions 2013-2018
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Regions 2018
    Table Market Top Trends
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Manufacturers (2013-2018)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Manufacturers in 2018
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Pulmonary Arterial Hypertension (PAH) Medicine Product/Solution/Service
    Table Date of Enter into Pulmonary Arterial Hypertension (PAH) Medicine Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Type (2013-2018)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Market Share by Type (2013-2018)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Application (2013-2018)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Market Share by Application (2013-2018)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Revenue Market Share by Application in 2017
    Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table United States Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table United States Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table United States Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table Europe Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table Europe Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table China Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table China Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table China Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table Japan Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table Japan Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table India Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table India Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table India Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Figure Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Pulmonary Arterial Hypertension (PAH) Medicine Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Pulmonary Arterial Hypertension (PAH) Medicine Market Share (2017-2018)
    Table Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Type (2013-2018)
    Table Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Share by Application (2013-2018)
    Table Pfizer Company Details
    Table Pfizer Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018) (Million US$)
    Figure Pfizer Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
    Table Pfizer Recent Development
    Table Gilead Sciences Company Details
    Table Gilead Sciences Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)(Million US$)
    Figure Gilead Sciences Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
    Table Gilead Sciences Recent Development
    Table Eli Lilly Company Details
    Table Eli Lilly Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)(Million US$)
    Figure Eli Lilly Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
    Table Eli Lilly Recent Development
    Table Actelion Pharmaceuticals Company Details
    Table Actelion Pharmaceuticals Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)(Million US$)
    Figure Actelion Pharmaceuticals Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
    Table Actelion Pharmaceuticals Recent Development
    Table United Therapeutics Corporation Company Details
    Table United Therapeutics Corporation Revenue in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)(Million US$)
    Figure United Therapeutics Corporation Revenue Growth Rate in Pulmonary Arterial Hypertension (PAH) Medicine Business (2013-2018)
    Table United Therapeutics Corporation Recent Development
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Regions (Million US$) 2018-2025
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Regions (2018-2025)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size Share by Regions in 2025
    Figure United States Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure China Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure India Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Pulmonary Arterial Hypertension (PAH) Medicine Market Size Forecast (2018-2025)(Million USD)
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Product (2018-2025) (Million US$)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Product (2018-2025)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Product in 2025
    Table Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2018-2025) (Million US$)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application (2018-2025)
    Figure Global Pulmonary Arterial Hypertension (PAH) Medicine Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.